Cargando…

A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer

PURPOSE: Aldo-ketoreductase (AKR) 1C3 is crucial for testosterone synthesis. Abnormally high expression/activity of AKR1C3 can promote castration-resistant prostate cancer (CRPC). A mansonone derivative and AKR1C3 inhibitor, 6e, was combined with 4D5 (extracellular fragment of the monoclonal antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Meng, Wang, Xiaoyu, Xia, Jie, Cheng, Yating, Xiao, Lichun, Bei, Yu, Tang, Jianzhong, Huang, Yadong, Xiang, Qi, Huang, Shiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200237/ https://www.ncbi.nlm.nih.gov/pubmed/32431503 http://dx.doi.org/10.2147/IJN.S241324

Ejemplares similares

IG1, a Mansonone F Analog, Exhibits Antibacterial Activity against Staphylococcus aureus by Potentially Impairing Cell Wall Synthesis and DNA Replication
por: Chen, Xin, et al.
Publicado: (2022)

Mansonone G and its derivatives exhibit membrane permeabilizing activities against bacteria
por: Htoo, Htut Htut, et al.
Publicado: (2022)

Allyl ether of mansonone G as a potential anticancer agent for colorectal cancer
por: Chanvijit, Savinee, et al.
Publicado: (2022)

Inhibition of castration-resistant prostate cancer growth by genistein through suppression of AKR1C3
por: Yu, Xiaoping, et al.
Publicado: (2023)

siAKR1C3@PPA complex nucleic acid nanoparticles inhibit castration-resistant prostate cancer in vitro
por: Cui, Xiaoli, et al.
Publicado: (2022)

AKR1C3 Inhibition Therapy in Castration-Resistant Prostate Cancer and Breast Cancer: Lessons from Responses to SN33638
por: Zhou, Wen, et al.
Publicado: (2014)

Enhanced Solubility and Anticancer Potential of Mansonone G By β-Cyclodextrin-Based Host-Guest Complexation: A Computational and Experimental Study
por: Mahalapbutr, Panupong, et al.
Publicado: (2019)

Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Zhu, Sha, et al.
Publicado: (2022)

Transforming Growth Factor-β3/Recombinant Human-like Collagen/Chitosan Freeze-Dried Sponge Primed With Human Periodontal Ligament Stem Cells Promotes Bone Regeneration in Calvarial Defect Rats
por: Huang, Shiyi, et al.
Publicado: (2021)

Butoxy Mansonone G Inhibits STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and Theoretical Investigations
por: Mahalapbutr, Panupong, et al.
Publicado: (2019)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer
por: Yin, Yarong Diana, et al.
Publicado: (2014)

Novel bone microenvironment model of castration-resistant prostate cancer with chitosan fiber matrix and osteoblasts
por: Samoto, Masahiro, et al.
Publicado: (2021)

Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer
por: Pang, Xiaocong, et al.
Publicado: (2019)

Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer
por: Liedtke, Andy J., et al.
Publicado: (2013)

AKR1C3 Converts Castrate and Post-Abiraterone DHEA-S into Testosterone to Stimulate Growth of Prostate Cancer Cells via 5-Androstene-3β,17β-Diol
por: Detlefsen, Andrea J., et al.
Publicado: (2023)

Review of Lutetium-177-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for the Treatment of Metastatic Castration-resistant Prostate Cancer
por: Niaz, Muhammad O, et al.
Publicado: (2020)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer
por: Ide, Hisamitsu, et al.
Publicado: (2018)

AKR1B10 expression in benign prostatic hyperplasia and its related mechanism
por: Xu, Wenjing, et al.
Publicado: (2021)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials
por: Tarrar, Talha Azam, et al.
Publicado: (2022)

The Effects of Matrine in Combination with Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer
por: Li, Qi, et al.
Publicado: (2019)

Dual Inhibitory Action of a Novel AKR1C3 Inhibitor on Both Full-Length AR and the Variant AR-V7 in Enzalutamide Resistant Metastatic Castration Resistant Prostate Cancer
por: Kafka, Mona, et al.
Publicado: (2020)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses
Publicado: (1981)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Molecular and cellular mechanisms of castration resistant prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018)

Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer
por: Shi, Sheng-Jia, et al.
Publicado: (2019)

Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
por: Schulze, Jenny J., et al.
Publicado: (2012)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Zhong, Shangwei, et al.
Publicado: (2021)

The Curcumin Derivative, H10, Suppresses Hormone-Dependent Prostate Cancer by Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3
por: Cheng, Yating, et al.
Publicado: (2020)

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)

Hybrid Freeze-Dried Dressings Composed of Epidermal Growth Factor and Recombinant Human-Like Collagen Enhance Cutaneous Wound Healing in Rats
por: Cheng, Yating, et al.
Publicado: (2020)

Silane Coupling Agent Modifies the Mechanical Properties of a Chitosan Microfiber
por: Shirosaki, Yuki, et al.
Publicado: (2020)

The role of glutamine metabolism in castration-resistant prostate cancer
por: Zhao, Bing, et al.
Publicado: (2023)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_34e3pne69m63dei149nh9d0cr3